Near-Term Outlook Muted on Pharma Stocks: Prashasta Seth

  • 5:35
  • Published On: October 28, 2015
Cinema View
Embed
Prashasta Seth, CEO of IIFL AMC, said pharma companies are facing pricing pressure in the US and many companies are facing regulatory issues. Until clarity emerges on these two fronts, pharma stocks may remain rangebound, he added.

Related Videos

Sensex, Nifty Fall Sharply, Snapping A Two Session Winning Streak
August 25, 2022 0:24
Worst Fall For Markets In 2 Months
August 22, 2022 0:57
Sensex, Nifty Extend Gains For Third Day; Tech, Metal Stocks Shine
June 27, 2022 0:28
Sensex Jumps Over 250 Points To Cross 40,000 Mark
May 31, 2019 0:55
Sensex Gains Over 200 Points As Markets Soar To All-Time Highs
May 21, 2019 2:29
Sensex Rises Over 200 Points, Nifty Moves Above 11,650
May 07, 2019 1:21
Bulls return to Dalal Street
August 14, 2017 1:45
Markets Edge Higher, Tata Steel Top Nifty Gainer
June 08, 2017 1:42
Like NMDC From Metals Pack:  Shrikant Shetty
February 14, 2017 29:42
Outlook For Metals, Crude In 2017
December 27, 2016 8:30
Bullish On Metals, IT And Financials: JP Morgan
December 14, 2016 24:15
Invest For Long Term Via SIPs: Chintan Haria
December 01, 2016 21:03
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination